urapidil has been researched along with buspirone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bönisch, H; Brüss, M; Göthert, M; Kostanian, A | 1 |
3 other study(ies) available for urapidil and buspirone
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.
Topics: Anti-Anxiety Agents; Arginine; Buspirone; Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Genetic Variation; Humans; Inhibitory Concentration 50; Leucine; Pharmacogenetics; Piperazines; Protein Binding; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Signal Transduction; Transfection | 2005 |